PAOG and PURA Announce Free Hemp Seed Giveaway To Promote CBD and Hemp Awareness
Sandusky, Ohio--(Newsfile Corp. - October 16, 2020) - PAO Group, Inc. (OTC Pink: PAOG) and Puration, Inc. (OTC Pink: PURA) today announced a free hemp seed giveaway in conjunction with the recent partnership between the two companies where PAOG will be building a hemp cultivation facility on PURA's Farmersville, Texas property.
To view an enhanced version of this graphic, please visit:
PAOG's hemp cultivation facility is central to the company's plans to develop a proprietary pharmaceutical grade hemp cultivar.
PURA recently announced a year long initiative to transition PURA from a CBD sports beverage manufacturer into a hemp conglomerate built on a lifestyle brand with a broad CBD consumer products reach, and a leading industrial hemp initiative. The brand name is Farmersville Brands and as part of their strategy, PURA has entered into a letter of intent (LOI) agreement to acquire 72 acers of agricultural property in Farmersville, Texas. PURA's year long initiative includes plans to see the Farmersville Brand strategy infused with a $100 million investment.
The free hemp seeds are intended to further public education on hemp and CBD. PAOG and PURA want to encourage free hemp seed participants to journal their growing experience on social media from start to finish. PAOG and PURA want to see participants show how easy it is to grow hemp; demonstrate the strength of the hemp fiber by trying to break a stalk either by themselves or with the help of any 10 friends, and please smoke the hemp flowers and experience how high you don't get. PAOG and PURA hope participants will conduct any number of creative experiments and share their results on social media.
The seeds will be coming from the PURA cultivation operation recently sold to PAOG in conjunction with PAOG's new initiative to develop CBD pharmaceuticals.
In addition to acquiring PURA's cannabis cultivation operation, On July 30, 2020, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for COPD derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT."
PAOG recently published a progress update on the company's ongoing initiative to advance an investigational New Drug application (IND) with the Food and Drug Administration (FDA). PAOG anticipates entering into an agreement with a contract research organization (CRO) within the next two weeks. The CRO engagement will be a major breakthrough in advancing PAOG's RespRx treatment for Chronic Obstructive Pulmonary Disease (COPD) toward FDA approval.
To get your free seeds visit https://www.paogroupinc.com/hemp-seeds . The first 1,000 to sign up will receive a free hemp seed sample.
Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/66173